Evidence map›Paper›PMID 38203252›Full record

ReviewInternational journal of molecular sciences2023

Essential-Oils-Loaded Biopolymeric Nanoparticles as Strategies for Microbial and Biofilm Control: A Current Status.

Alejandra Romero-Montero, Luis Javier Melgoza-Ramírez, Jesús Augusto Ruíz-Aguirre, Alejandra Chávez-Santoscoy, Jonathan Javier Magaña, Hernán Cortés, Gerardo Leyva-Gómez, María Luisa Del Prado-Audelo

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Hydroxypropyl Cellulose Hydrogel ContainingGels (Basel, Switzerland) · 2024
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alejandra Romero-MonteroDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0002-3953-3002
Luis Javier Melgoza-RamírezTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Mexico City 14380, Mexico.ORCID 0009-0000-5356-7252
Jesús Augusto Ruíz-AguirreTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Mexico City 14380, Mexico.
Alejandra Chávez-SantoscoyTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Campus Monterrey, Ave. Eugenio Garza Sada 2501 Sur, Monterrey 64849, Mexico.ORCID 0000-0002-4551-1862
Jonathan Javier MagañaTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Mexico City 14380, Mexico.
Hernán CortésLaboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.ORCID 0000-0002-6147-4109
Gerardo Leyva-GómezDepartamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0002-7940-1100
María Luisa Del Prado-AudeloTecnologico de Monterrey, Escuela de Ingeniería y Ciencias, Mexico City 14380, Mexico.
Tecnológico de Monterrey · MXInstituto Nacional de Rehabilitación · MXUniversidad Nacional Autónoma de México · MX

Funding

CONAHCYT CVU: 629447DGAPA-UNAM PAPIIT IN204722
6 · The paper itself

Abstract

The emergence of bacterial strains displaying resistance to the currently available antibiotics is a critical global concern. These resilient bacteria can form biofilms that play a pivotal role in the failure of bacterial infection treatments as antibiotics struggle to penetrate all biofilm regions. Consequently, eradicating bacteria residing within biofilms becomes considerably more challenging than their planktonic counterparts, leading to persistent and chronic infections. Among various approaches explored, essential oils loaded in nanoparticles based on biopolymers have emerged, promising strategies that enhance bioavailability and biological activities, minimize side effects, and control release through regulated pharmacokinetics. Different available reviews analyze nanosystems and essential oils; however, usually, their main goal is the analysis of their antimicrobial properties, and progress in biofilm combat is rarely discussed, or it is not the primary objective. This review aims to provide a global vision of biofilm conformation and describes mechanisms of action attributed to each EO. Furthermore, we present a comprehensive overview of the latest developments in biopolymeric nanoparticles research, especially in chitosan- and zein-based nanosystems, targeting multidrug-resistant bacteria in both their sessile and biofilm forms, which will help to design precise strategies for combating biofilms.

Indexed as

NanoparticlesOils, VolatileAnti-Bacterial AgentsBiofilmsBiological AvailabilityAnti-Bacterial AgentsOils, Volatilebiofilmchitosan nanoparticlesessential oilsnatural productsphytochemicals

Identifiers

PMID38203252
PMCPMC10778842
OpenAlexW4389998940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.